Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Prestigious editorial board appointment for Associate Professor Andy Philp

Prestigious editorial board appointment for Associate Professor Andy Philp

Date time 8 May, 2023
News Type News type Research News
Associate Professor Andy Philp – Director of the Centenary Institute’s Centre for Healthy Ageing and an internationally renowned expert in skeletal muscle wasting disorders ¬ has been invited onto the editorial board of the respected Journal of Cachexia, Sarcopenia and Muscle (JCSM).

JCSM is the flagship journal of the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD), dedicated to publishing research relevant to changes in body composition, especially cachexia (loss of muscle mass due to an underlying illness) and sarcopenia (loss of muscle mass due to ageing), as consequences of chronic illnesses or of the ageing process.

As an editorial board member, Associate Professor Philp will provide expert advice on journal policy and subject matter, help attract high-quality manuscripts as well as assist in the peer review process.

“I’m honoured to be taking on this exciting role and look forward to being actively involved in such a well-regarded and influential science journal,“ said Associate Professor Philp.

“There is a need to advance important new knowledge to better understand the processes of muscle deterioration in numerous chronic diseases of ageing. As a member of the editorial board, I hope to be able to enhance the journal’s already excellent reputation in this critical health space and further promote the visibility of SCWD.”

The Journal of Cachexia, Sarcopenia and Muscle is highly ranked and sits in the top 5% of all geriatrics and ageing journals for impact.

Themes

  • Healthy Ageing

    Healthy Ageing

People

  • Professor Andy Philp

    Visiting Researcher

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Tuberculosis research symposium hosted at the Centenary Institute

    The Centenary Institute recently hosted the 2026 Tuberculosis Centre of Research Excellence (TB-CRE) Annual Research Symposium. The event brought together leading researchers, clinicians and tuberculosis (TB) program partners dedicated to tackling TB across Australia and the Asia-Pacific region.
    News Type: Research News
    Date 10 Jun 2026
  • Regenerative focused research grant to repair and restore damaged hearts

    The Centenary Institute’s Associate Professor Dan Hesselson has been awarded $750,000 to accelerate pioneering research into heart regeneration, through a prestigious Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program, funded by NSW Health.
    News Type: Media release
    Date 02 Jun 2026
  • Justin Clancy MP visits Centenary Institute

    The Centenary Institute recently welcomed Justin Clancy MP, Shadow Minister for Medical Research on-site, providing laboratory tours and a firsthand look at research focused on improving health outcomes for Australians.
    News Type: Institute
    Date 27 May 2026
  • Centenary researchers aim to improve diagnosis of heavy menstrual bleeding

    The Centenary Institute is implementing a new research program aimed at improving the diagnosis and care of women experiencing heavy menstrual bleeding.
    News Type: Research News
    Date 21 May 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram